Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Emerging As World Power In Stem Cell Research

This article was originally published in PharmAsia News

Executive Summary

BEIJING - China is speedily evolving into a global power in terms of stem cell research, with the central government stepping up funding and recruiting scientists worldwide in order to catapult the country into the advance ranks of regenerative medicine, according to four scholars at the University of Toronto

You may also be interested in...



Pharma Innovation Increasingly Viable In Middle-Income Countries

R&D spending grew 455% among PhRMA members in Asia between 2005 and 2010, compared to increases of 112% in Latin America and 303% in India, according to IFPMA survey.

Sanofi-Aventis Asia Pacific R&D Head Frank Jiang Sees Progress And Promise In Research Alliances Across China

BEIJING - As the Paris-headquartered Sanofi-Aventis expands its matrix of research alliances across China, this virtual R&D web is beginning to churn out tangible signs of progress and promise, according to a high-ranking Sanofi scientist based in China

Sanofi-Aventis Asia Pacific R&D Head Frank Jiang Sees Progress And Promise In Research Alliances Across China

BEIJING - As the Paris-headquartered Sanofi-Aventis expands its matrix of research alliances across China, this virtual R&D web is beginning to churn out tangible signs of progress and promise, according to a high-ranking Sanofi scientist based in China

Related Content

UsernamePublicRestriction

Register

SC073132

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel